Verrica Pharmaceuticals Inc. Earnings Per Share (Basic)
Verrica Pharmaceuticals Inc. (VRCA) reported Earnings Per Share (Basic) of -$0.62 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.62, a 3200.00% decline year-over-year.
- Verrica Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.45.
- Verrica Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.03.
- Verrica Pharmaceuticals Inc. earnings per share, basic for the quarter ending 2025-06-30 was $0.02.
- Verrica Pharmaceuticals Inc. earnings per share, basic for fiscal 2025 was -$1.68.
- Verrica Pharmaceuticals Inc. earnings per share, basic for fiscal 2024 was -$14.78.
- Verrica Pharmaceuticals Inc. earnings per share, basic for fiscal 2023 was -$1.48.
- Verrica Pharmaceuticals Inc. earnings per share, basic for fiscal 2022 was -$0.72.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.62 10-Q · filed 2026-08-06 | -$1.07 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.45 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | -$1.68 10-K · filed 2026-03-11 | |||||||
| 2025-09-30 | -$0.03 10-Q · filed 2025-11-14 | -$1.03 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | $0.02 10-Q · filed 2026-08-06 | -$1.01 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$1.03 10-Q · filed 2026-05-12 | -$0.10 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | -$14.78 10-K · filed 2026-03-11 | -$1.48 10-K · filed 2025-03-11 | ||||||
| 2024-09-30 | -$4.88 10-Q · filed 2025-11-14 | -$0.49 10-Q · filed 2024-11-05 | -$12.96 10-Q · filed 2025-11-14 | -$1.30 10-Q · filed 2024-11-05 | ||||
| 2024-06-30 | -$3.70 10-Q · filed 2025-08-12 | -$0.37 10-Q · filed 2024-08-14 | -$8.07 10-Q · filed 2025-08-12 | -$0.81 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$0.44 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | -$1.48 10-K · filed 2025-03-11 | |||||||
| 2023-09-30 | -$0.54 10-Q · filed 2024-11-05 | -$0.94 10-Q · filed 2024-11-05 | ||||||
| 2023-06-30 | -$0.24 10-Q · filed 2024-08-14 | -$0.40 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.15 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$0.72 10-K · filed 2024-02-29 | |||||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | -$0.58 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.37 10-Q · filed 2023-08-08 | -$0.68 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$0.31 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | -$1.30 10-K · filed 2023-03-06 | |||||||
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-07 | -$0.95 10-Q · filed 2022-11-07 | ||||||
| 2021-06-30 | -$0.43 10-Q · filed 2022-08-11 | -$0.46 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |